Gary D. Hammer, MD, PhD, serves as the Director of the Endocrine Oncology Program in the Comprehensive Cancer Center at UM where he holds the Millie Schembechler Professorship in Adrenal Cancer. Under his leadership, the Program was selected as one of five inaugural Destination Programs at UM singled out for combined research and clinical excellence. The Program is uniquely recognized as an international center of excellence for the treatment of adrenal cancer.
He is also the Director of the Center for Organogenesis that brings together groups and faculty – basic scientists and clinicians – focused on organ-specific problems spanning developmental disorders to cancer.
Research projects in his laboratory are aimed at elucidating the mechanisms by which growth factor signaling and transcriptional programs initiate adrenal-specific growth and differentiation with an emphasis on stem/progenitor cells in development and cancer. This work has led to the development of new international therapeutic trials with biological-based therapies.